Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia 8Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Non-Hodgkin 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Recurrence 4Neoplasms 4Multiple Myeloma 4Hodgkin Disease 4Lymphoma, Mantle-Cell 3Lymphoma 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Chronic 3Primary Myelofibrosis 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Congenital Abnormalities 2Burkitt Lymphoma 2Wilms Tumor 1Testicular Neoplasms 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1

Interventions

Cyclophosphamide 3Busulfan 3Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Filgrastim 2Arsenic Trioxide 2tamibarotene 1fludarabine phosphate 1Tretinoin 1Mycophenolic Acid 1Idarubicin 1Clofarabine 1Bortezomib 1Antilymphocyte Serum 1Alemtuzumab 1AEG 35156 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Promyelocytic, Acute × Clofarabine × Clear all
NCT00852709 2018-02-15

POE07-01

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Terminated
35 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡